The protective effects of bexarotene against advanced glycation end-product (AGE)-induced degradation of articular extracellular matrix (ECM)
AbstractOsteoarthritis (OA) is a common debilitating disease primarily characterised by excessive loss of the articular ECM, which is composed of up to 95% type II collagen. Among the factors that contribute to the pathogenesis of OA, the natural process of aging is regarded as the most significant...
Main Authors: | Zhuqing Zha, Qingmin Han, Shaochuan Huo |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Artificial Cells, Nanomedicine, and Biotechnology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21691401.2019.1699802 |
Similar Items
-
Photodegradation of Bexarotene and Its Implication for Cytotoxicity
by: Agata Kryczyk-Poprawa, et al.
Published: (2021-08-01) -
RXRα agonist bexarotene attenuates radiation-induced skin injury by relieving oxidative stress
by: Sheng Jiang, et al.
Published: (2022-06-01) -
Treatment of Rosai–Dorfman disease with oral bexarotene: a case series
by: Shamir Geller, et al.
Published: (2019-07-01) -
Indolent adult T‐cell leukaemia‐lymphoma successfully treated with bexarotene in an eldery patient
by: Maho Nakashima, et al.
Published: (2023-12-01) -
Cocrystal Prediction of Bexarotene by Graph Convolution Network and Bioavailability Improvement
by: Fu Xiao, et al.
Published: (2022-10-01)